Cytogenetic evolution of patients with unusual karyotypic abnormalities
UPN . | At diagnosis . | Mo 3 . | Mo 6 . | Mo 9 . | Mo 12 . |
|---|---|---|---|---|---|
| 423 | t(7,9,22): 100% | 5% | 0% | ND | 0% |
| 925 | t(9,20,22): 100% | 16% | 0% | 2% | 0% |
| 102 | +8: 3% Ph: 100% | 10% | 6% | 0% | 9% |
| 315 | t(9,22)t(9,14) 100% | NE | 100% | NE | 86% |
| 1504 | Masked Ph: FISH 98% | FISH 31% | NE | FISH 4% | FISH 5.7% |
| 1212 | Klinefelter 100% | NE | NE | FISH 5% | FISH 0% |
UPN . | At diagnosis . | Mo 3 . | Mo 6 . | Mo 9 . | Mo 12 . |
|---|---|---|---|---|---|
| 423 | t(7,9,22): 100% | 5% | 0% | ND | 0% |
| 925 | t(9,20,22): 100% | 16% | 0% | 2% | 0% |
| 102 | +8: 3% Ph: 100% | 10% | 6% | 0% | 9% |
| 315 | t(9,22)t(9,14) 100% | NE | 100% | NE | 86% |
| 1504 | Masked Ph: FISH 98% | FISH 31% | NE | FISH 4% | FISH 5.7% |
| 1212 | Klinefelter 100% | NE | NE | FISH 5% | FISH 0% |
UPN indicates unique patient number; ND, not determined; NE, not evaluable; and %, percent of Ph+ cells.